Triple-negative breast cancer (TNBC) represents 15–20% of breast cancer cases and is associated with a lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) expression [2]. This evidence concerns the gene ERBB2 and breast carcinoma.